Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Shares Issued: 2009-2025

Historic Shares Issued for Gyre Therapeutics (GYRE) over the last 8 years, with Sep 2025 value amounting to $1.3 million.

  • Gyre Therapeutics' Shares Issued rose 242.25% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 92.37%. This contributed to the annual value of $1.9 million for FY2024, which is 24.00% down from last year.
  • Per Gyre Therapeutics' latest filing, its Shares Issued stood at $1.3 million for Q3 2025, which was up 24.03% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Shares Issued peaked at $49.3 million during Q1 2021, and registered a low of $275,000 during Q2 2024.
  • Moreover, its 2-year median value for Shares Issued was $658,000 (2024), whereas its average is $738,286.
  • Data for Gyre Therapeutics' Shares Issued shows a peak YoY surged of 275.27% (in 2025) over the last 5 years.
  • Over the past 3 years, Gyre Therapeutics' Shares Issued (Quarterly) stood at $49.3 million in 2021, then reached $593,000 in 2024, then soared by 242.25% to $1.3 million in 2025.
  • Its Shares Issued was $1.3 million in Q3 2025, compared to $1.0 million in Q2 2025 and $956,000 in Q1 2025.